Local Ablative Therapies for Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference70 articles.
1. Local treatment of oligometastatic recurrence in patients with resected non–small cell lung cancer;Lung Cancer,2013
2. Patterns of distant metastases after surgical management of non–small-cell lung cancer;Clin Lung Cancer,2017
3. Oligometastases;J Clin Oncol,1995
4. Oligometastases revisited;Nat Rev Clin Oncol,2011
5. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Lancet,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review;Expert Review of Respiratory Medicine;2023-09-02
2. Immunotherapy in Advanced NSCLC Without Driver Mutations: Available Therapeutic Alternatives After Progression and Future Treatment Options;Clinical Lung Cancer;2022-12
3. Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study;Cancer Medicine;2022-06-05
4. The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer;Lung Cancer;2021-11
5. Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression;Cancers;2021-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3